Ian F. Smith, EVP & CFO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 10,350 shares at $125.98 ($1.3M) on 2015-10-30, disclosed to the SEC on 2015-11-03.
Scheduled sale ($1.3M) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $124.95 | 2,800 | $350K | 26.9% |
| 2 | $125.98 | 4,865 | $613K | 47.0% |
| 3 | $126.62 | 2,685 | $340K | 26.1% |
| Total | $125.87 avg | 10,350 | $1.3M | 100% |
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |